Skip to content
Politically.com Search all
Menu

2025 · 3rd Quarter (July 1 - Sep 30)

AMGEN

Filed by MR. DAN CRIPPEN.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-09-16 06:26:08 UTC.

Source-reported fields

Filing overview

Type
3rd Quarter - Report
Posted
Oct 1, 2025
Income
$36,000.00
Expenses
Not reported
Registrant
MR. DAN CRIPPEN
Client
AMGEN
Filing UUID
b66dd891-2874-4365-8090-a923b78e3964
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

PHA · Pharmacy

pharmacy rebates and discounts pharmacy R&D

ECN · Economics/Economic Development

pharmacy rebates and discounts

GOV · Government Issues

congressional procedure

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.